Temperature: The Single Most Important Factor for Degradation of Glucose Fluids during Storage

Objective Bioincompatible glucose degradation products (GDPs) develop during heat sterilization of peritoneal dialysis (PD) fluids. However, degradation may also take place during storage. Consequently, storage may add to the bioincompatibility caused by heat sterilization. The aim of the present study was to investigate how different factors such as the sterilization procedure, pH, glucose concentration, and temperature influence GDP production during storage. Design Degradation in glucose solutions was followed by pH and UV absorbance at 228 nm and 284 nm over 2 years of storage. Different sterilization times, storage temperatures, pH, and glucose concentrations were included in the study. Peritoneal dialysis fluids were also used in the experiment. Bioincompatibility was estimated through inhibition of cell growth in L-929 fibroblasts, and GDPs through UV absorption and liquid chromatography. Results The most important factor determining the rate of GDP production during storage was temperature. The GDPs created by heat sterilization promoted further degradation of glucose during subsequent storage. A pH of around 3.2 protected glucose from degradation during both heat sterilization and storage. At a storage temperature of 20°C and a pH of 3.2, degradation was almost negligible. Heat sterilization produced considerable amounts of GDPs absorbing at 228 nm. During initial storage, these 228 nm-absorbing GDPs almost disappeared. After reaching a nadir, absorbance at 228 nm again started to increase. Contrary to this, absorbance at 284 nm [caused mainly by 5-hydroxymethyl-2-furaldehyde (5-HMF)] increased during the whole storage period. After 2 years at 40°C, the concentrations of GDPs produced during storage were of the same magnitude as those caused by heat sterilization. Inhibition of cell growth of L-929 fibroblasts correlated well with the part of the absorbance at 228 nm not caused by 5-HMF in glucose solutions that were heat sterilized under a wide range of conditions. This part of 228 nm absorbance (denoted 228corr) was caused almost entirely by 3,4-dideoxyglucosone-3-ene (3,4-DGE). Conclusions Temperature is the single most important factor for glucose degradation during storage. The concentrations of bioincompatible GDPs produced may, under improper conditions, be as high as those produced during sterilization. High concentrations of glucose and low pH protect glucose from being degraded during both sterilization and storage. A good estimate of 3,4-DGE concentration in the fluids can be obtained correcting the UV absorbance at 228 nm for the influence from 5-HMF (and, when appropriate, for lactate). The 228corr may thus be used as a simple quality control for the fluids.

[1]  A. Wieslander,et al.  3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis. , 2002, Kidney international.

[2]  A. Tauer,et al.  How to Reduce 3-Deoxyglucosone and Acetaldehyde in Peritoneal Dialysis Fluids , 2002, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[3]  A. Wieslander,et al.  Glucose Degradation Products in Peritoneal Dialysis Fluids May Have Both Local and Systemic Effects: A Study of Residual Fluid and Mesothelial Cells , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[4]  A. Wieslander,et al.  Degradation in Peritoneal Dialysis Fluids May be Avoided by Using Low pH and High Glucose Concentration , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[5]  A. Christensson,et al.  Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. , 2001, Kidney international.

[6]  M. Tuncer,et al.  Chemical peritonitis associated with high dialysate acetaldehyde concentrations. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  T. Henle,et al.  3-Deoxyglucosone, a Promoter of Advanced Glycation end Products in Fluids for Peritoneal Dialysis , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[8]  A. Wieslander,et al.  Clinical and Physiological Effects of a New, Less Toxic and Less Acidic Fluid for Peritoneal Dialysis , 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[9]  L. Henderson,et al.  Impact of terminal heat sterilization on the quality of peritoneal dialysis solutions. , 1997, Blood purification.

[10]  A. Wieslander,et al.  Less infusion pain and elevated level of cancer antigen 125 by the use of a new and more biocompatible PD fluid. , 1996, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[11]  B. Holmquist,et al.  Development of Toxic Degradation Products during Heat Sterilization of Glucose-Containing Fluids for Peritoneal Dialysis: Influence of Time and Temperature , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[12]  A. Wieslander,et al.  Heat Sterilization of Fluids for Peritoneal Dialysis Gives Rise to Aldehydes , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[13]  A. Wieslander,et al.  Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. , 1993, Clinical nephrology.

[14]  A. Wieslander,et al.  Toxicity of heat sterilized peritoneal dialysis fluids is derived from degradation of glucose. , 1992, ASAIO journal.

[15]  A. Wieslander,et al.  Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. , 1991, Kidney international.